New Option for Eosinophilic Esophagitis?

(MedPage Today) -- In patients with eosinophilic esophagitis (EoE), a special formulation of the corticosteroid budesonide was superior to placebo in improving histologic, symptomatic, and endoscopic outcomes over 12 weeks, researchers reported...